Servier Acquires Menin Inhibitor BN104 from BioNova

McDermott Will & Schulte has advised Servier on the acquisition of BN104 from BioNova.Servier, an international, independent pharmaceutical group governed by a foundation, has completed the…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here